Alyeska Investment Group
OXFD

Alyeska Investment Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,341,518
Closed -$23.4M 942
2020
Q4
$23.4M Sell
1,341,518
-766,381
-36% -$13.4M 0.33% 89
2020
Q3
$24.7M Buy
2,107,899
+220,168
+12% +$2.58M 0.37% 85
2020
Q2
$24.5M Buy
1,887,731
+436,087
+30% +$5.67M 0.37% 88
2020
Q1
$13.4M Buy
1,451,644
+152,144
+12% +$1.41M 0.27% 109
2019
Q4
$21.6M Sell
1,299,500
-502,148
-28% -$8.34M 0.28% 117
2019
Q3
$30M Buy
1,801,648
+151,802
+9% +$2.52M 0.43% 83
2019
Q2
$22.7M Buy
1,649,846
+928,998
+129% +$12.8M 0.29% 110
2019
Q1
$12.4M Sell
720,848
-597,417
-45% -$10.3M 0.16% 150
2018
Q4
$16.8M Sell
1,318,265
-282,279
-18% -$3.61M 0.25% 125
2018
Q3
$26M Sell
1,600,544
-13,671
-0.8% -$222K 0.28% 105
2018
Q2
$20.8M Buy
1,614,215
+52,159
+3% +$672K 0.19% 146
2018
Q1
$19.4M Buy
1,562,056
+161,153
+12% +$2.01M 0.16% 151
2017
Q4
$19.6M Buy
1,400,903
+45,374
+3% +$634K 0.16% 151
2017
Q3
$22.8M Buy
1,355,529
+413,904
+44% +$6.95M 0.17% 162
2017
Q2
$15.8M Sell
941,625
-10,844
-1% -$182K 0.13% 197
2017
Q1
$14.8M Buy
952,469
+83,504
+10% +$1.29M 0.12% 219
2016
Q4
$13M Buy
868,965
+12,087
+1% +$181K 0.11% 251
2016
Q3
$10.8M Buy
856,878
+39,187
+5% +$492K 0.1% 253
2016
Q2
$7.36M Buy
817,691
+16,590
+2% +$149K 0.07% 272
2016
Q1
$7.94M Buy
801,101
+10,235
+1% +$101K 0.07% 254
2015
Q4
$9.1M Sell
790,866
-118,465
-13% -$1.36M 0.1% 216
2015
Q3
$12.3M Buy
909,331
+43,305
+5% +$585K 0.14% 190
2015
Q2
$12M Buy
866,026
+14,029
+2% +$194K 0.14% 196
2015
Q1
$12M Buy
851,997
+502,722
+144% +$7.08M 0.17% 195
2014
Q4
$4.76M Buy
349,275
+18,363
+6% +$250K 0.08% 260
2014
Q3
$5.05M Sell
330,912
-15,650
-5% -$239K 0.1% 211
2014
Q2
$5.83M Buy
346,562
+16,129
+5% +$271K 0.13% 194
2014
Q1
$6.63M Sell
330,433
-130,652
-28% -$2.62M 0.18% 142
2013
Q4
$8.94M Buy
+461,085
New +$8.94M 0.35% 85